Summary:
This program involves 15 in-house days and nights with a 7-10 day break and again staying for another 15 in-house days and nights. The study medication is a dietary supplement of amino acid formulation made up of proteins. The liver plays a central role in amino acid metabolism and, consequently, patients with liver disease show abnormalities in their plasma amino acid profile.
Qualified Participants Must:
• Have mild to moderate liver disease
•
Be ages 18- 75 years
Qualified Participants May Receive:
Financial compensation for this trial is up to $7,930.00.